Literature DB >> 27862886

Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.

Amy K Bruzek1, Andrew H Zureick2, Paul E McKeever3, Hugh J L Garton1, Patricia L Robertson4, Rajen Mody5, Carl J Koschmann5.   

Abstract

Pediatric spinal oligodendrogliomas are rare and aggressive tumors. They do not share the same molecular features of adult oligodendroglioma, and no previous reports have examined the molecular features of pediatric spinal oligodendroglioma. We present the case of a child with a recurrent spinal anaplastic oligodendroglioma. We performed whole exome (paired tumor and germline DNA) and transcriptome (tumor RNA) sequencing, which revealed somatic mutations in NF1 and FGFR1. These data allowed us to explore potential personalized therapies for this patient and expose molecular drivers that may be involved in similar cases.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  NF1; anaplastic oligodendroglioma; fibroblast growth factor receptor type 1; molecular sequence data; precision medicine; spinal cord neoplasms

Mesh:

Substances:

Year:  2016        PMID: 27862886      PMCID: PMC5611838          DOI: 10.1002/pbc.26346

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

Review 1.  Targeting the fibroblast growth factor receptor family in cancer.

Authors:  Niamh Hallinan; Stephen Finn; Sinead Cuffe; Shereen Rafee; Kenneth O'Byrne; Kathy Gately
Journal:  Cancer Treat Rev       Date:  2016-04-12       Impact factor: 12.111

2.  Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib.

Authors:  Robert Sheppard Nickel; Marla Daves; Frank Keller
Journal:  Pediatr Blood Cancer       Date:  2015-05-04       Impact factor: 3.167

3.  BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults.

Authors:  Andrew S Chi; Tracy T Batchelor; Daniel Yang; Dora Dias-Santagata; Darrell R Borger; Leif W Ellisen; A John Iafrate; David N Louis
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

4.  High-grade pediatric spinal cord tumors.

Authors:  T E Merchant; D Nguyen; S J Thompson; D A Reardon; L E Kun; R A Sanford
Journal:  Pediatr Neurosurg       Date:  1999-01       Impact factor: 1.162

5.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Authors:  Fulin Wang; Guangyu Qiao; Xin Lou
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

Review 6.  Intramedullary spinal cord tumour associated with neurofibromatosis type 1.

Authors:  T Yagi; K Ohata; M Haque; A Hakuba
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

7.  Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.

Authors:  Kenneth J Cohen; Ian F Pollack; Tianni Zhou; Allen Buxton; Emiko J Holmes; Peter C Burger; Daniel J Brat; Marc K Rosenblum; Ronald L Hamilton; Robert S Lavey; Richard L Heideman
Journal:  Neuro Oncol       Date:  2011-03       Impact factor: 12.300

8.  Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients.

Authors:  Tryggve Lundar; Bernt Johan Due-Tønnessen; Arild Egge; David Scheie; Einar Stensvold; Petter Brandal
Journal:  J Neurosurg Pediatr       Date:  2013-07-19       Impact factor: 2.375

Review 9.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

10.  Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.

Authors:  Douglas J Hyder; Lillian Sung; Ian F Pollack; Floyd H Gilles; Allen J Yates; Richard L Davis; James M Boyett; Jonathan L Finlay
Journal:  J Neurooncol       Date:  2007-01-25       Impact factor: 4.506

View more
  1 in total

1.  Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.

Authors:  Sydney T Grob; Liana Nobre; Kristen R Campbell; Kurtis D Davies; Scott Ryall; Dara L Aisner; Lindsey Hoffman; Shadi Zahedi; Andrew Morin; Michele Crespo; Anandani Nellan; Adam L Green; Nicholas Foreman; Rajeev Vibhakar; Todd C Hankinson; Michael H Handler; Cynthia Hawkins; Uri Tabori; B K Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  Neurooncol Adv       Date:  2020-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.